Article: Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia

2.42

SKU: product-article-13984 Category:

Description

Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia

Reviews

There are no reviews yet.

Be the first to review “Article: Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia”

Your email address will not be published. Required fields are marked *